{"id":34699,"date":"2024-11-26T17:12:53","date_gmt":"2024-11-26T17:12:53","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=34699"},"modified":"2024-11-26T17:12:53","modified_gmt":"2024-11-26T17:12:53","slug":"what-is-the-most-efficacious-acceptable-and-cost-effective-way-to-screen-for-liver-disease-in-the-community","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/sq\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/type-2-rcf-funded-projects\/what-is-the-most-efficacious-acceptable-and-cost-effective-way-to-screen-for-liver-disease-in-the-community\/","title":{"rendered":"Cila \u00ebsht\u00eb m\u00ebnyra m\u00eb efikase, e pranueshme dhe me kosto efektive p\u00ebr t\u00eb kontrolluar s\u00ebmundjet e m\u00ebl\u00e7is\u00eb n\u00eb komunitet?"},"content":{"rendered":"
Seksioni me titull module-1<\/span><\/a>
\r\n
\r\n

Cila \u00ebsht\u00eb m\u00ebnyra m\u00eb efikase, e pranueshme dhe me kosto efektive p\u00ebr t\u00eb kontrolluar s\u00ebmundjet e m\u00ebl\u00e7is\u00eb n\u00eb komunitet?<\/h1>\n

Financimi:<\/h1>\n

Financimi i Aft\u00ebsive K\u00ebrkimore t\u00eb BNSSG ICB.<\/p>\n

Cili \u00ebsht\u00eb problemi?<\/h2>\n

90% e t\u00eb gjitha s\u00ebmundjeve t\u00eb m\u00ebl\u00e7is\u00eb mund t\u00eb parandalohen dhe vijn\u00eb ose p\u00ebr shkak t\u00eb alkoolit, obezitetit ose viruseve. Pavar\u00ebsisht k\u00ebsaj, nd\u00ebrsa t\u00eb gjitha shkaqet e tjera t\u00eb m\u00ebdha t\u00eb vdekjes bien, vdekjet p\u00ebr shkak t\u00eb s\u00ebmundjeve t\u00eb m\u00ebl\u00e7is\u00eb vazhdojn\u00eb t\u00eb rriten. S\u00ebmundja e m\u00ebl\u00e7is\u00eb tani ka tejkaluar vet\u00ebvrasjen si nj\u00eb nga shkaqet kryesore t\u00eb vdekjes tek njer\u00ebzit n\u00eb mosh\u00eb pune n\u00eb Mbret\u00ebrin\u00eb e Bashkuar. Alkooli, obeziteti dhe viruset mund t\u00eb d\u00ebmtojn\u00eb m\u00ebl\u00e7in\u00eb, duke shkaktuar formimin e shenjave (fibroz\u00eb). Kur k\u00ebto shenja nuk mund t\u00eb kthehen mbrapsht, kjo quhet cirroz\u00eb. Pasi pacient\u00ebt kan\u00eb cirroz\u00eb, ata jan\u00eb n\u00eb rrezik shum\u00eb m\u00eb t\u00eb lart\u00eb p\u00ebr nd\u00ebrlikime, t\u00eb tilla si konfuzioni, \u00ebnjtja e barkut me l\u00ebng ose gjakderdhja nga zorr\u00ebt. Megjithat\u00eb, n\u00ebse cirroza ose shenjat e k\u00ebqija t\u00eb m\u00ebl\u00e7is\u00eb (fibroza) zbulohen her\u00ebt, kjo u lejon mjek\u00ebve t\u00eb fillojn\u00eb trajtimin e pacient\u00ebve. Trajtimi p\u00ebrfshin mb\u00ebshtetje me ndryshime n\u00eb stilin e jet\u00ebs, fillimin e medikamenteve dhe monitorimin e pacient\u00ebve p\u00ebr kancerin e m\u00ebl\u00e7is\u00eb. Shpresa \u00ebsht\u00eb se kjo i ndalon pacient\u00ebt t\u00eb zhvillojn\u00eb nd\u00ebrlikime.<\/p>\n

Aktualisht, pacient\u00ebt kan\u00eb nevoj\u00eb q\u00eb mjeku i tyre i familjes t\u00eb dyshoj\u00eb se kan\u00eb s\u00ebmundje t\u00eb m\u00ebl\u00e7is\u00eb p\u00ebr ta testuar at\u00eb. Problemi \u00ebsht\u00eb se pacient\u00ebt nuk do t\u00eb ken\u00eb simptoma derisa t\u00eb ken\u00eb nd\u00ebrlikime t\u00eb cirroz\u00ebs.<\/p>\n

Ne kemi teste t\u00eb mira p\u00ebr t\u00eb zbuluar s\u00ebmundjet e m\u00ebl\u00e7is\u00eb dhe cirroz\u00ebn, duke p\u00ebrfshir\u00eb analizat e gjakut dhe skanimet speciale t\u00eb m\u00ebl\u00e7is\u00eb. Ajo q\u00eb nuk dim\u00eb \u00ebsht\u00eb (1) m\u00ebnyra m\u00eb e mir\u00eb p\u00ebr t\u00eb porositur k\u00ebto teste, (2) cila \u00ebsht\u00eb m\u00ebnyra m\u00eb efektive nga ana e kostos p\u00ebr t\u00eb testuar njer\u00ebzit (3) \u00e7far\u00eb do t\u00eb zbuloj\u00eb m\u00eb shum\u00eb s\u00ebmundje t\u00eb m\u00ebl\u00e7is\u00eb dhe (4) cila rrug\u00eb \u00ebsht\u00eb m\u00eb e leht\u00eb p\u00ebr t'u ndjekur nga pacient\u00ebt.<\/p>\n

Cili \u00ebsht\u00eb q\u00ebllimi i hulumtimit?<\/strong><\/h2>\n

Q\u00ebllimi i p\u00ebrgjithsh\u00ebm \u00ebsht\u00eb t\u00eb hartohet nj\u00eb prov\u00eb p\u00ebr t\u00eb testuar njer\u00ebzit p\u00ebr s\u00ebmundjen e m\u00ebl\u00e7is\u00eb n\u00eb komunitet dhe p\u00ebr ta krahasuar k\u00ebt\u00eb testim me kujdesin normal q\u00eb pacient\u00ebt marrin tani. Prova do t\u00eb zhvillohet duke p\u00ebrdorur praktika t\u00eb shumta mjek\u00ebsh t\u00eb p\u00ebrgjithsh\u00ebm n\u00eb t\u00eb gjith\u00eb vendin.<\/p>\n

Pastaj do t\u00eb testonim n\u00ebse \u00ebsht\u00eb m\u00eb e lir\u00eb n\u00eb p\u00ebrgjith\u00ebsi t\u00eb testojm\u00eb njer\u00ebzit p\u00ebr s\u00ebmundje t\u00eb m\u00ebl\u00e7is\u00eb n\u00eb komunitet n\u00eb k\u00ebt\u00eb m\u00ebnyr\u00eb.<\/p>\n

Si do t\u00eb arrihet kjo?<\/h2>\n

Faza 1 \u2013 12 muaj prov\u00eb.<\/em> 38 klinika t\u00eb mjek\u00ebve t\u00eb p\u00ebrgjithsh\u00ebm n\u00eb t\u00eb gjith\u00eb vendin do t\u00eb ftohen t\u00eb marrin pjes\u00eb. \u00c7do klinik\u00eb do t\u00eb zgjidhet rast\u00ebsisht p\u00ebr t'u b\u00ebr\u00eb pjes\u00eb e "krahut t\u00eb nd\u00ebrhyrjes" ose "krahut t\u00eb kontrollit".<\/p>\n

Brenda "krahut t\u00eb nd\u00ebrhyrjes", nj\u00eb p\u00ebrzgjedhje e rast\u00ebsishme e pacient\u00ebve q\u00eb plot\u00ebsojn\u00eb kriteret p\u00ebr t\u00eb qen\u00eb n\u00eb prov\u00eb do t\u00eb ftohet p\u00ebr t'u kontrolluar p\u00ebr s\u00ebmundje t\u00eb m\u00ebl\u00e7is\u00eb me analiza gjaku, skanime t\u00eb m\u00ebl\u00e7is\u00eb dhe pyet\u00ebsor\u00eb shtes\u00eb sh\u00ebndet\u00ebsor\u00eb. Pyetjet e b\u00ebra do t\u00eb p\u00ebrfshijn\u00eb sasin\u00eb e alkoolit t\u00eb konsumuar dhe probleme t\u00eb tjera sh\u00ebndet\u00ebsore q\u00eb pacient\u00ebt mund t\u00eb ken\u00eb. K\u00ebta pacient\u00eb do t\u00eb ndiqen p\u00ebr 1 vit.<\/p>\n

Pacient\u00ebt q\u00eb plot\u00ebsojn\u00eb kriteret duhet t\u00eb jen\u00eb midis 40 dhe 75 vje\u00e7. Ata do t\u00eb duhet t\u00eb ken\u00eb ose analiza t\u00eb larta t\u00eb gjakut n\u00eb m\u00ebl\u00e7i, ose t\u00eb ken\u00eb nj\u00eb histori t\u00eb konsumimit t\u00eb tep\u00ebrt t\u00eb alkoolit, ose t\u00eb ken\u00eb diabet t\u00eb tipit 2, ose t\u00eb ken\u00eb obezitet. Pacient\u00ebt q\u00eb tashm\u00eb kan\u00eb s\u00ebmundje t\u00eb m\u00ebl\u00e7is\u00eb, kancer ose q\u00eb jan\u00eb t\u00eb s\u00ebmur\u00eb n\u00eb faz\u00eb terminale nuk do t\u00eb p\u00ebrfshihen n\u00eb prov\u00eb.<\/p>\n

Ne do t\u00eb ndjekim pacient\u00ebt e rekrutuar n\u00eb "krahun e kontrollit" p\u00ebr 1 vit p\u00ebr t\u00eb par\u00eb n\u00ebse ata referohen n\u00eb sh\u00ebrbimet e m\u00ebl\u00e7is\u00eb.<\/p>\n

Faza 2 \u2013 Analiza. Pasi t\u00eb kemi informacionin nga prova 12-mujore, do ta p\u00ebrdorim at\u00eb informacion p\u00ebr t'iu p\u00ebrgjigjur:<\/p>\n

    \n
  1. Sa cirroz\u00eb u gjet.<\/li>\n
  2. Sa nga referimet nuk kishin s\u00ebmundje t\u00eb r\u00ebnd\u00eb t\u00eb m\u00ebl\u00e7is\u00eb<\/li>\n
  3. Sa pacient\u00eb q\u00eb u referuan vazhduan t\u00eb pranoheshin me nd\u00ebrlikime t\u00eb m\u00ebl\u00e7is\u00eb n\u00eb vitin e par\u00eb.<\/li>\n
  4. A ishte m\u00eb pak e kushtueshme t\u00eb zbulohej s\u00ebmundja e m\u00ebl\u00e7is\u00eb p\u00ebrmes prov\u00ebs n\u00eb krahasim me standardin aktual t\u00eb kujdesit.<\/li>\n
  5. A menduan pacient\u00ebt se rruga e prov\u00ebs ishte n\u00eb rregull.<\/li>\n<\/ol>\n

    Kush po e udh\u00ebheq hulumtimin?<\/strong><\/h2>\n

    Dr. Kushala Abeysekera, Lektore Klinike Akademike n\u00eb Sh\u00ebndetin Publik dhe Epidemiologjin\u00eb: Gastroenterologji, Shkolla Mjek\u00ebsore e Bristolit.<\/p>\n

    Informacion i m\u00ebtejsh\u00ebm<\/h2>\n

    Rreth Dr. Kushala Abeysekera<\/a>.<\/p>\n

    P\u00ebr m\u00eb shum\u00eb informacion ose p\u00ebr t'u p\u00ebrfshir\u00eb n\u00eb k\u00ebt\u00eb projekt, ju lutemi t\u00eb kontaktoni\u00a0bnssg.research@nhs.net<\/a>.<\/p>\n

    <\/h2>\n <\/div>\r\n <\/section><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

    Section titled module-1 What is the most efficacious, aceptable and cost effective way to screen for liver disease in the community? Funding: BNSSG ICB Research Capability Funding. What is the problem? 90% of all liver disease can be prevented and is either due to alcohol, obesity or viruses. Despite this, whilst all the other big […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":32896,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-34699","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/comments?post=34699"}],"version-history":[{"count":2,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34699\/revisions"}],"predecessor-version":[{"id":34701,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34699\/revisions\/34701"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/32896"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/media?parent=34699"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/tags?post=34699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}